Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test. Aliment Pharmacol Ther. 2021;53:939–940.

Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test. Aliment Pharmacol Ther. 2021;53:939–940.

August 2020

Source:

Publication: